Diagnosis and Management of Noncardiac Complications in Adults With Congenital Heart Disease: A Scientific Statement From the American Heart Association
congenital hypertension causes :: Article Creator MicroRNA In Blood Could Be PAH Marker In Congenital Heart Disease High levels of a small RNA molecule in the blood may be a marker of pulmonary arterial hypertension (PAH) in people with congenital heart diseases, a new study reveals. The study, "Expression and Diagnostic Value of miR-3591-5p in Patients with Congenital Heart Disease-Associated Pulmonary Arterial Hypertension," was published in Lung. PAH is marked by high blood pressure in the vessels that carry blood through the lungs. People with congenital heart disease (CHD), a broad category that encompasses problems with heart structure or function from birth, are at high risk of developing PAH. MicroRNAs, often abbreviated miRNAs, are small pieces of RNA that regulate gene activity within cells. The impact of these small RNA molecules in human disease is only starting to be understood, but research suggests it could be immens...